A case of verapamil-rifampin interaction is presented in a patient receiving verapamil for supraventricular tachycardia (SVT) and rifampin for pulmonary tuberculosis. The patient experienced recurrent symptomatic SVT, despite receiving verapamil 480 mg po q6h. Serum verapamil concentrations were determined to be extremely low. Discontinuation of rifampin and substitution of ethambutol resulted in an almost four-fold increase in verapamil levels with concurrent control of SVT. Rifampin may have increased the metabolism of verapamil by inducing hepatic microsomal enzymes resulting in low verapamil levels and failure to control SVT.
BakySHSinghBN. Verapamil hydrochloride: Pharmacological properties and role in cardiovascular therapeutics. Pharmacotherapy1982; 2: 328–53.
2.
BaciewiczAMSelfTH. Rifampin drug interactions. Arch Intern Med1984; 144: 1667–71.
3.
RahnKHMooyJBöhmRVetAVD. Reduction of bioavailability of verapamil by rifampin (letter). New Engl J Med1985; 312: 920–1.
4.
WoodcockBGHopfRKaltenbachM. Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy. J Cardiovasc Pharmacol1980; 2: 17–23.
5.
FreedmanSBRichmondDRAshleyJJKellyDT. Verapamil kinetics in normal subjects and patients with coronary artery spasm. Clin Pharmacol Ther1981; 30: 644–52.
SchwartzJBKeefeDLKirstenEKatesREHarrisonDC. Prolongation of verapamil elimination kinetics during chronic oral administration. Am Heart J1982; 104: 198–203.
8.
HarapatSRKatesRE. High-performance liquid chromatographic analysis of verapamil II. Simultaneous quantification of verapamil and its active metabolite, norverapamil. J Chromatogr1980; 181: 484–9.
9.
SchomerusMSpiegelhalderBStierenBEichelbaumM. Physiologic disposition of verapamil in man. Cardiovasc Res1976; 10: 605–12.
10.
EichelbaumMSomogiAVon UnruhGEDenglerHJ. Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D, L-verapamil using stable isotope-labelled verapamil. Eur J Clin Pharmacol1981; 19: 133–7.
11.
RemmerHSchoneBFleischmannRA. Induction of the unspecific microsomal hydroxylase in the human liver. Drug Metab Dispos1973; 1: 224–9.
12.
BoltHMKappusHBoltM. Effect of rifampicin treatment on the metabolism of oestradiol and 17-ethinyloestradiol by human liver microsomes. Eur J Clin Pharmacol1975; 8: 301–7.
13.
JezequelAMOrlandiFTenconiLT. Changes of the smooth endoplasmic reticulum induced by rifampicin in human and guinea-pig hepatocytes. Gut1971; 12: 984–7.
14.
BreimerDDZillyWRichterE. Influence of rifampicin on drug metabolism: Differences between phenobarbital and antipyrine. Clin Pharmacol Ther1975; 21: 470–81.
15.
WilkinsonGRShandDG. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther1975; 18: 377–90.
